Journals Library

HTA - 15/46/02

Methylphenidate versus placebo for fatigue in advanced cancer (MePFAC)

Project title: Methylphenidate versus placebo for fatigue in advanced cancer (MePFAC)

Call to action: 15/46 15/46 Methylphenidate in cancer-related fatigue

Research type: Primary Research

Chief investigator: Professor Patrick StoneORCID logo

Contractor: University College London

Cost: £1,690,010.07

Co-investigators: Dr Ollie MintonORCID logo, Dr Rachael HunterORCID logo, Professor Alison RichardsonORCID logo, Professor Michael KingORCID logo, Professor Nick FreemantleORCID logo.

Started: May 2017 | Status: Research in progress

ISRCTN: 79478762

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked


How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.